A highly efficient indirect ELISA and monoclonal antibody established against African swine fever virus pK205R

Liwei Li, Sina Qiao, Jiachen Liu, Yanjun Zhou, Tong Wu, Shishan Dong, Changlong Liu, Yifeng Jiang, Ziqiang Guo, Haihong Zheng, Ran Zhao, Guangzhi Tong, Guoxin Li, Fei GaoFrontiers in Immunology 2023 · DOI

TL;DR

Researchers have developed a high-efficiency indirect ELISA and a specific monoclonal antibody (mAb) targeting the pK205R protein of African Swine Fever Virus (ASFV). By utilizing a mammalian suspension culture system for protein expression and mapping a highly conserved "universal" epitope, this study provides robust new tools for both early clinical diagnosis and the monitoring of next-generation vaccine candidates.

What Problem Does This Paper Address?

African Swine Fever (ASF) is the "black death" of the pig industry—highly contagious, nearly 100% lethal in some strains, and currently without a commercially available vaccine or effective antiviral treatment. Controlling outbreaks relies heavily on rapid detection and strict biosecurity.

While several ASFV proteins are used for diagnostics, pK205R is a particularly attractive target because it is expressed early in the infection cycle and triggers a strong antibody response. However, previous diagnostic tools often relied on proteins produced in bacterial systems (E. coli), which can suffer from misfolding or lack essential post-translational modifications. There is a pressing need for high-quality, mammalian-expressed antigens and highly specific monoclonal antibodies to improve the sensitivity of surveillance and support vaccine research.

Methods

The authors took a multi-pronged approach to build a better diagnostic toolkit:

  • Mammalian Expression System: Instead of traditional prokaryotic expression, the team used 293i cells in a suspension culture. This allowed the pK205R protein to be secreted and folded correctly, mimicking its natural state during infection.
  • ELISA Optimization: They established an indirect ELISA using the purified pK205R as the coating antigen, optimizing concentrations and incubation times to maximize the signal-to-noise ratio.
  • Monoclonal Antibody Generation: Using the purified protein, they generated a specific mAb (clone 2H11).
  • Epitope Mapping: To understand exactly where the mAb binds, they used a series of truncated protein fragments and synthetic peptides.
  • Vaccine Vector Validation: They tested the utility of their tools by monitoring antibody levels in piglets vaccinated with a recombinant PRRSV (Porcine Reproductive and Respiratory Syndrome Virus) vector designed to express the ASFV pK205R protein.

Datasets

  • Clinical Samples: 162 swine serum samples were used to compare the new ELISA against a standard commercial kit.
  • Reference Strains: Genomic sequences from 25 representative ASFV strains (covering multiple genotypes including I, II, VIII, IX, X, and XXII) were used for alignment to verify epitope conservation.
  • Specificity Panel: Sera from pigs infected with other common viruses (CSFV, PRV, PRRSV, PEDV, FMDV, and PCV2) were used to ensure the assay did not produce false positives.

Key Insights and Ideas

  • The "Universal" Epitope: The most significant finding was that mAb 2H11 recognizes a linear epitope ($^2$VEPREQFFQDLLSAV$^{16}$) located at the N-terminus of the protein. Sequence alignment revealed this sequence is 100% conserved across all 25 analyzed ASFV strains. This suggests the tools developed here could work globally, regardless of the local ASFV genotype.
  • Superiority of Mammalian Expression: By using 293i cells, the researchers obtained a protein that was highly antigenic and "cleaner" for ELISA coating, leading to high sensitivity without the background noise often seen with bacterially derived proteins.
  • Dual-Utility: The study demonstrates that these tools aren't just for finding the virus in the wild; they are essential for "Differentiating Infected from Vaccinated Animals" (DIVA) strategies and monitoring the performance of viral-vectored vaccines.

Key Results

  • High Sensitivity: The indirect ELISA could detect ASFV-positive sera at dilutions as high as 1:1280.
  • Clinical Performance: In a head-to-head trial with 162 clinical samples, the developed ELISA identified 54 positives, while a leading commercial kit identified 53. This indicates a coincidence rate of 99.38%, with the new assay potentially being slightly more sensitive.
  • Vaccine Tracking: The ELISA successfully tracked the rise of antibodies in piglets vaccinated with the vA-ASFV-K205R vector, showing a clear seroconversion starting at 14 days post-vaccination and peaking at 42 days.
  • Absolute Specificity: The assay showed zero cross-reactivity with other major swine pathogens, confirming its reliability for field surveillance.

Limitations and Future Work

  • Functional Mystery: While the paper establishes pK205R as a great diagnostic marker, its exact biological role in ASFV pathogenesis (beyond its known involvement in ER stress and autophagy) remains a subject for future structural biology research.
  • Broader Validation: While 25 strains were analyzed, ASFV is highly diverse. Testing the ELISA against a wider array of live wild-type isolates from different geographic regions would further solidify its "universal" status.
  • Vaccine Efficacy: The study uses pK205R as a marker for a PRRSV-vectored vaccine, but whether pK205R itself contributes significantly to protective immunity (rather than just being a good marker) is still an open question in the quest for a final ASF vaccine.

Summary updated

Abstract

African swine fever (ASF) is a contagious infectious disease with high lethality which continuously threatens the global pig industry causing huge economic losses. Currently, there are no commercially available vaccines or antiviral drugs that can effectively control ASF. The pathogen of ASF, ASF virus (ASFV) is a double-stranded DNA virus with a genome ranging from 170 to 193 kb and 151 to 167 open reading frames in various strains, which encodes 150-200 proteins. An effective method of monitoring ASFV antibodies, and specific antibodies against ASFV to promote the development of prevention techniques are urgently needed. In the present study, pK205R of ASFV was successfully expressed in mammalian cells using a suspension culture system. An indirect enzyme-linked immunosorbent assay (ELISA) based on the purified pK205R was established and optimized. The monoclonal antibody (mAb) against pK205R recognized a conservative linear epitope (<sup>2</sup>VEPREQFFQDLLSAV<sup>16</sup>) and exhibited specific reactivity, which was conducive to the identification of the recombinant porcine reproductive and respiratory syndrome virus (PRRSV) expressing pK205R. The ELISA method efficiently detected clinical ASFV infection and revealed good application prospects in monitoring the antibody level <i>in vivo</i> for recombinant PRRSV live vector virus expressing the ASFV antigen protein. The determination of the conserved linear epitope of pK205R would contribute to further research on the structural biology and function of pK205R. The indirect ELISA method and mAb against ASFV pK205R revealed efficient detection and promising application prospects, making them ideal for epidemiological surveillance and vaccine research on ASF.
BibTeX
@inproceedings{li2023highly,
  author = {Liwei Li and Sina Qiao and Jiachen Liu and Yanjun Zhou and Tong Wu and Shishan Dong and Changlong Liu and Yifeng Jiang and Ziqiang Guo and Haihong Zheng and Ran Zhao and Guangzhi Tong and Guoxin Li and Fei Gao},
  title = {{A highly efficient indirect ELISA and monoclonal antibody established against African swine fever virus pK205R}},
  booktitle = {Frontiers in Immunology},
  year = {2023},
  doi = {10.3389/fimmu.2022.1103166},
}
Figure